Septic embolism · people with endocarditis due to Staphylococcus aureus in drug abusers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cure4 · people with endocarditis caused by Staphylococcus aureus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for cardiac surgical interventions · people with endocarditis due to Staphylococcus aureus in drug abusers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Uncontrolled infection · people with endocarditis due to Staphylococcus aureus in drug abusers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality during hospital stay and all‐cause mortality at 1 year · people with infective endocarditis due to penicillin‐susceptible Streptococci
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cure · people with infective endocarditis due to penicillin‐susceptible Streptococci
Beta‐lactam (ceftriaxone) plus aminoglycoside (gentamicin) showed no clear difference in cure compared with beta‐lactam (ceftriaxone) (low certainty).
1 finding from 1 review
Adverse events · people with infective endocarditis due to penicillin‐susceptible Streptococci
It is very uncertain whether beta‐lactam (ceftriaxone) plus aminoglycoside (gentamicin) changes adverse events compared with beta‐lactam (ceftriaxone) (very low certainty).
1 finding from 1 review
Congestive heart failure · people with infective endocarditis due to penicillin‐susceptible Streptococci
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Septic embolism · people with infective endocarditis due to penicillin‐susceptible Streptococci
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for cardiac surgical interventions · people with infective endocarditis due to penicillin‐susceptible Streptococci
It is very uncertain whether beta‐lactam (ceftriaxone) plus aminoglycoside (gentamicin) changes need for cardiac surgical interventions compared with beta‐lactam (ceftriaxone) (very low certainty).
1 finding from 1 review
Uncontrolled infection · people with infective endocarditis due to penicillin‐susceptible Streptococci
It is very uncertain whether beta‐lactam (ceftriaxone) plus aminoglycoside (gentamicin) changes uncontrolled infection compared with beta‐lactam (ceftriaxone) (very low certainty).
1 finding from 1 review
All‐cause mortality during hospital stay and all‐cause mortality at 1 year · people with infective endocarditis due to methicillin‐resistant Staphylococcus aureus
It is very uncertain whether fosfomycin plus imipenem changes all‐cause mortality during hospital stay and all‐cause mortality at… compared with vancomycin (very low certainty).
1 finding from 1 review
RR 7 [0.47, 103.27]
1 study · 8 participants
Very low
Adverse events4 · people with endocarditis caused by Staphylococcus aureus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cure · people with infective endocarditis due to methicillin‐resistant Staphylococcus aureus
It is very uncertain whether fosfomycin plus imipenem changes cure compared with vancomycin (very low certainty).
1 finding from 1 review
RR 0.5 [0.07, 3.55]
1 study · 8 participants
Very low
Adverse events · people with infective endocarditis due to methicillin‐resistant Staphylococcus aureus
It is very uncertain whether fosfomycin plus imipenem changes adverse events compared with vancomycin (very low certainty).
1 finding from 1 review
RR 1 [0.25, 4]
1 study · 8 participants
Very low
Congestive heart failure · people with infective endocarditis due to methicillin‐resistant Staphylococcus aureus
It is very uncertain whether fosfomycin plus imipenem changes congestive heart failure compared with vancomycin (very low certainty).
1 finding from 1 review
RR 9 [0.64, 126.85]
1 study · 8 participants
Very low
Septic embolism · people with infective endocarditis due to methicillin‐resistant Staphylococcus aureus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for cardiac surgical interventions · people with infective endocarditis due to methicillin‐resistant Staphylococcus aureus
It is very uncertain whether fosfomycin plus imipenem changes need for cardiac surgical interventions compared with vancomycin (very low certainty).
1 finding from 1 review
RR 2 [0.28, 14.2]
1 study · 8 participants
Very low
Uncontrolled infection · people with infective endocarditis due to methicillin‐resistant Staphylococcus aureus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality during hospital stay and all‐cause mortality at 1 year · people with endocarditis on the left side of the heart (on native or prosthetic valves) with bacteraemia for Streptococcus, Enterococcus…
It is very uncertain whether partial oral treatment changes all‐cause mortality during hospital stay and all‐cause mortality at… compared with conventional intravenous treatment of endocarditis on the left side… (very low certainty).
1 finding from 1 review